We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > F-star

News List

Lilly and Verge Genomics partner to use AI for drug development pharmaceutical-technology
July 12, 2021
Eli Lilly has entered a three-year partnership with biotech company Verge Genomics to research and create new drugs for the treatment of amyotrophic lateral sclerosis (ALS), a motor neuron disease.
F-star expands its relationship with Merck pharmaasia
June 19, 2017
New strategic collaboration to develop and commercialise five bispecific immuno-oncology antibodies, including F-star’s lead asset FS118.
F-Star Expands Relationship with Merck to Develop Bispecific Antibodies in Immuno-Oncology americanpharmaceuticalreview
June 07, 2017
F-star announced a new partnership with Merck for the development and commercialization of five bispecific immuno-oncology antibodies (mAb2).